Can I read Empagliflozin Dosing in Type 2 Diabetes on EtoBox?

Empagliflozin Dosing in Type 2 Diabetes by Ian Cantalice is a document available to read on EtoBox.

What is Empagliflozin Dosing in Type 2 Diabetes about?

This network meta-analysis examines the efficacy and safety of empagliflozin at various doses in patients with type 2 diabetes mellitus (T2DM). It concludes that higher daily doses (10, 25, 50 mg) are more effective than lower doses (1, 2.5, 5 mg) for reducing HbA1c and fasting plasma glucose, with 25 mg showing the best overall performance. The analysis also indicates a dose-response trend for adverse effects, suggesting that safety decreases with increasing doses.

Author

Ian Cantalice

Language

EN